Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Syed, Maha N., Shah, Mohsin, Shin, Daniel B., Wan, Marilyn T., Winthrop, Kevin L., Gelfand, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448776/
https://www.ncbi.nlm.nih.gov/pubmed/32860913
http://dx.doi.org/10.1016/j.jaad.2020.08.095
_version_ 1783574540197036032
author Syed, Maha N.
Shah, Mohsin
Shin, Daniel B.
Wan, Marilyn T.
Winthrop, Kevin L.
Gelfand, Joel M.
author_facet Syed, Maha N.
Shah, Mohsin
Shin, Daniel B.
Wan, Marilyn T.
Winthrop, Kevin L.
Gelfand, Joel M.
author_sort Syed, Maha N.
collection PubMed
description
format Online
Article
Text
id pubmed-7448776
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-74487762020-08-27 Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic Syed, Maha N. Shah, Mohsin Shin, Daniel B. Wan, Marilyn T. Winthrop, Kevin L. Gelfand, Joel M. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2021-01 2020-08-26 /pmc/articles/PMC7448776/ /pubmed/32860913 http://dx.doi.org/10.1016/j.jaad.2020.08.095 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Syed, Maha N.
Shah, Mohsin
Shin, Daniel B.
Wan, Marilyn T.
Winthrop, Kevin L.
Gelfand, Joel M.
Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
title Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
title_full Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
title_fullStr Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
title_full_unstemmed Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
title_short Effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic
title_sort effect of anti–tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis—a meta-estimate of pivotal phase 3 trials relevant to decision making during the covid-19 pandemic
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448776/
https://www.ncbi.nlm.nih.gov/pubmed/32860913
http://dx.doi.org/10.1016/j.jaad.2020.08.095
work_keys_str_mv AT syedmahan effectofantitumornecrosisfactortherapyontheriskofrespiratorytractinfectionsandrelatedsymptomsinpatientswithpsoriasisametaestimateofpivotalphase3trialsrelevanttodecisionmakingduringthecovid19pandemic
AT shahmohsin effectofantitumornecrosisfactortherapyontheriskofrespiratorytractinfectionsandrelatedsymptomsinpatientswithpsoriasisametaestimateofpivotalphase3trialsrelevanttodecisionmakingduringthecovid19pandemic
AT shindanielb effectofantitumornecrosisfactortherapyontheriskofrespiratorytractinfectionsandrelatedsymptomsinpatientswithpsoriasisametaestimateofpivotalphase3trialsrelevanttodecisionmakingduringthecovid19pandemic
AT wanmarilynt effectofantitumornecrosisfactortherapyontheriskofrespiratorytractinfectionsandrelatedsymptomsinpatientswithpsoriasisametaestimateofpivotalphase3trialsrelevanttodecisionmakingduringthecovid19pandemic
AT winthropkevinl effectofantitumornecrosisfactortherapyontheriskofrespiratorytractinfectionsandrelatedsymptomsinpatientswithpsoriasisametaestimateofpivotalphase3trialsrelevanttodecisionmakingduringthecovid19pandemic
AT gelfandjoelm effectofantitumornecrosisfactortherapyontheriskofrespiratorytractinfectionsandrelatedsymptomsinpatientswithpsoriasisametaestimateofpivotalphase3trialsrelevanttodecisionmakingduringthecovid19pandemic

Ejemplares similares